Early research (Phase 1)Ended earlyNCT00575419
What this trial is testing
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
Who this might be right for
Contrast Induced Nephropathy
Oregon Health and Science University 6